Industry updates and investment insights—including investor behavior and fundraising advice—were among the topics experts ...

Japanese Ambassador to China Kenji Kanasugi met Monday with a Japanese citizen who has been detained in Beijing for about two years on suspicion of espionage, a Japanese government source said. The ...

Sutro Biopharma, Inc.’s STRO share price has dipped by 10.88%, which has investors questioning if this is right time to buy.

The number of Japanese nationals in China is decreasing amid the detention of expatriates working there and the country's ...

PHARMACEUTICAL company Indies Pharma Jamaica Limited has secured US$405,000 or just over $60 million in its first drawdown ...

Astellas Pharma and Yaskawa Electric have signed a definitive agreement to establish a joint venture aimed at advancing cell therapy manufacturing through automation. According to Astellas, the ...

The patentee was the Regents of the University of California, with Astellas Pharma Inc., Astellas Pharma Europe Ltd, and Astellas Pharma (Pty) Ltd (collectively referred to as Astellas), registered ...

Astellas Pharma and Yaskawa have agreed to form a JV that will focus on developing a cell therapy product manufacturing platform.

(RTTNews) - Japan's Astellas Pharma Inc. (ALPMY, ALPMY) announced that it has signed a definitive agreement with YASKAWA Electric Corp. to establish a joint venture for the development of a cell ...

(PRNewsFoto/Astellas Pharma Inc.) In the pharmaceutical industry, the commercialization of cell therapy faces many challenges stemming from the complex nature of the manufacturing process ...

In March 2025, Merck Sharp & Dohme LLC announced a study are to learn if people who receive V940 and pembrolizumab are alive ...

Astellas Pharma and Yaskawa Electric Corporation formalized a development deal signed last year that will see the two Japanese companies invest 3.5 billion Yen ($30.5 million) into developing an ...